• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHANG Jingxin,WANG Chunge,LI Wenlong,HU Kexin,CHENG Ting,HU Xi.Neuroprotective effects of Zhinao Capsule against cerebral ischemia-reperfusion injury in rats and its anti-apoptotic mechanisms[J].Journal Of Pharmaceutical Research,2026,45(9):975-982[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 214times   Download 206次 QR Code for this article
Scan with your phone!
智脑胶囊对大鼠脑缺血再灌注损伤的神经保护作用及其抗凋亡机制
张晶鑫1,2,王春格1,2,李文龙1,2,胡可欣1,2,程婷3,胡希1,2
Font:Larger+|Default|Smaller-
(1.安徽中医药大学药学院,安徽 合肥 230012;2.国家转化医学科学中心<上海>合肥分中心,安徽 合肥 230012;3.安徽中医药大学第一附属医院,安徽 合肥 230031)
摘要:
目的 探讨智脑胶囊对大鼠脑缺血再灌注损伤(CIRI)的神经保护作用及其抗凋亡机制。方法 将雄性SD大鼠随机分为假手术组、模型组及智脑胶囊低、中、高剂量组(0.234、0.468、0.936 g·kg-1)。除假手术组外,其余各组采用右侧大脑中动脉阻塞法建立CIRI模型,并于造模前连续7 d灌胃给药。术后评估脑损伤程度、脑组织病理改变、氧化应激指标及炎性因子水平,并检测凋亡相关蛋白的表达水平。结果 与模型组相比,智脑胶囊中、高剂量组脑梗死面积缩小,神经功能改善(P<0.05),脑组织病理损伤减轻,微管相关蛋白2(MAP2)表达增强。各剂量组丙二醛(MDA)含量降低,超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GSH-Px)活性升高,炎性因子水平下降(P<0.05)。智脑胶囊能够剂量依赖性地上调脑组织中磷酸化磷脂酰基醇3-激酶(PI3K)和磷酸化蛋白激酶B(Akt)蛋白表达水平,并下调糖原合成激酶-3β(GSK-3β)表达;同时上调B细胞淋巴瘤-2蛋白(Bcl-2)表达,下调Bcl-2相关X蛋白(Bax)及半胱氨酸蛋白酶-3(caspase-3)表达,并减少末端脱氧核苷酸转移酶dUTP缺口末端标记(TUNEL)阳性细胞数(P<0.05)。结论 智脑胶囊可减轻大鼠CIRI并保护神经元,其机制涉及缓解氧化应激、抑制神经炎症以及调控PI3K/AKT/GSK-3β凋亡相关信号通路。
关键词:  脑缺血再灌注损伤  智脑胶囊  神经保护  氧化应激  抗凋亡
DOI:10.13506/j.cnki.jpr.2026.09.003
基金项目:安徽中医药大学“基础-临床融合”专项面上项目(No.JCLCA2025010)
Received Date:January 31, 2026   Revision Date:May 12, 2026   Publication Date:September 30, 2026
Neuroprotective effects of Zhinao Capsule against cerebral ischemia-reperfusion injury in rats and its anti-apoptotic mechanisms
ZHANG Jingxin1,2,WANG Chunge1,2,LI Wenlong1,2,HU Kexin1,2,CHENG Ting3,HU Xi1,2
(1.School of Pharmacy,Anhui University of Chinese Medicine,Hefei 230012,China;2.Hefei Branch,National Center for Translational Medicine Science , Hefei 230012,China;3.The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031,China)
Abstract:
Objective>/b> To investigate the preventive neuroprotective effects of Zhinao Capsule on cerebral ischemia–reperfusion injury (CIRI) in rats and to explore its anti-apoptotic mechanisms. Methods Male Sprague-Dawley rats were randomly divided into a sham-operated group, a model group, and low-, medium-, and high-dose Zhinao Capsule groups (0.234, 0.468, and 0.936 g·kg-1). Except for the sham group, a CIRI model was established by right middle cerebral artery occlusion. Zhinao Capsule was administered by gavage for 7 consecutive days prior to model induction. Following the establishment of the CIRI model, the degree of cerebral injury, histopathological alterations, oxidative stress profiles, and inflammatory cytokine levels, and apoptosis-related protein expression were comprehensively evaluated. Results Compared with the model group, the medium- and high-dose Zhinao Capsule groups showed significantly reduced cerebral infarct areas and improved neurological function scores (P<0.05), accompanied by alleviated histopathological damage and enhanced microtubule-associated protein 2 (MAP2) expression. Malondialdehyde (MDA) levels decreased, while superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities significantly increased across all treatment groups, and inflammatory cytokines levels were markedly reduced (P<0.05). The expression levels of phosphorylated phosphatidylinositol-3-kinase (PI3K) and phosphorylated protein kinase B (Akt) proteins were upregulated in all dosage groups, while glycogen synthase kinase-3β (GSK-3β) expression was downregulated. Concurrently, apoptosis-related proteins B-cell lymphoma factor-2 (Bcl-2) expression increased, whereas Bcl-2-related X protein (Bax) and cysteine aspartate protease-3 (caspase-3) expression decreased, and the number of TUNEL-positive cells was significantly reduced (P<0.05). Conclusion Zhinao Capsule can alleviate CIRI in rats and protect damaged neurons, likely by reducing oxidative stress, suppressing neuroinflammation, and activating the PI3K/Akt/GSK-3β signaling pathway.
Key words:  Cerebral ischemia-reperfusion injury  Zhinao Capsules  Neuroprotection  Oxidative stress  Anti-apoptosis
Today's Visits:447    Total Visits:2383131
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.